The solitary mission that we believe in is making every patient feel easy & motivating them
as halcyon days are nearby.
Corneal Transplant & Advanced Eye Care in India for African Patients: Costs, Outcomes & Travel Guide (2026)
Have you been told there's no donor cornea available where you live, or that you'll lose the sight in that eye? This page is for you specifically.
Quick answer: Corneal transplant in India runs roughly $1,500-5,000 for standard procedures, with published one-year graft survival around 86% overall and close to 90% for keratoconus specifically. India's domestic eye bank network means donor tissue is typically available within days, rather than the long, import-dependent waits common across much of Africa.
Last reviewed: 25 August 2026.
If you've already been told no at home — no donor available, an open-ended waiting list, or a price for imported tissue you simply can't meet — you're not alone, and there is a real path forward. This guide walks through it honestly, including the parts that aren't perfect.
You've been told a corneal transplant is needed, but no donor tissue is available. You've been placed on a waiting list with no clear date. You've been quoted a price for imported donor tissue you can't afford. You have keratoconus and your vision keeps worsening despite glasses or contact lenses. You have corneal scarring from an old infection, injury, or previous surgery. A previous graft has failed and you've been told nothing more can be done. Or you've simply been told you'll permanently lose sight in one or both eyes. This page also covers cataract complications, retinal detachment, diabetic eye disease and glaucoma, though corneal disease is where we're starting — and where the strongest reason to travel actually lies.
Why African Patients Travel to India for Eye Surgery
Here's the argument that actually matters, more than price: donor tissue availability. Most African countries have no functioning eye bank at all. Where eye banks do exist — Ethiopia and Kenya each run one, the two with the most reach on the continent — demand still commonly outpaces domestic supply, and private-sector care leans on imported corneas, largely from the US, at a cost most patients simply can't meet. Globally, corneal disease affects an estimated 4.5 million people, and access to transplantable tissue is nowhere near even.
To put that in perspective: the World Health Organization's most recent figures put vision impairment at 2.2 billion people worldwide, with roughly 1 billion of those cases either preventable or still unaddressed — and one in two people globally who need cataract surgery simply don't have access to it. Corneal blindness sits inside that same picture of unmet need, concentrated hardest exactly where eye banking infrastructure is thinnest.
India runs its own domestic eye bank network. That means surgery can often happen within days of arrival, not months on a list with no end date. Beyond tissue supply, India also offers access to more advanced techniques — DMEK and DSEK, not only full-thickness PK — and keratoprosthesis where donor tissue genuinely isn't an option. And ophthalmic conditions sit on India's list of visa-priority conditions, which is a real, practical advantage when you apply.
We'll be honest about the flip side too: a corneal graft needs long-term follow-up, and that's genuinely harder to manage from another continent. We're naming that here, and we've built the back half of this page specifically to solve it.
The Cost of Delaying
Keratoconus usually starts correctable with lenses. Left alone, cross-linking may still halt its progression — but wait too long, and a transplant becomes the only option. Corneal scarring can also worsen over time, and longstanding disease can complicate surgery and lower the odds of a good outcome. Longer visual deprivation can affect how fully your vision recovers even after a technically successful graft. We won't run a countdown timer at you — but delay here has a real clinical cost, not just an emotional one.
Our Process & Timeline
Share your reports — corneal topography, slit lamp findings, visual acuity, prior surgical history, and photographs if you have them.
Get a written opinion with a cost estimate segmented by procedure type, not a single number.
Receive your hospital invitation letter.
Apply for your medical visa — ophthalmic conditions get priority consideration; up to two attendants can travel with you.
Travel and arrive.
Pre-operative assessment and tissue matching.
Surgery.
Immediate post-op period and discharge.
Follow-up planning — the part that matters most. Most competitor pages stop before this step. We don't.
Most patients from our research plan for a two-to-three-week trip, though this varies by procedure and healing.
Cost & Packages by Procedure Type
The internet quotes "corneal transplant" costs anywhere from $600 to $50,000, and that spread has a clean explanation almost nobody states plainly: it depends entirely on which procedure you actually need.
Procedure
India (indicative)
USA benchmark
PK — full-thickness
$3,000-15,000
$10,000-30,000
DSEK — partial, endothelial
$3,500-18,000
$12,000-35,000
DMEK — advanced endothelial, faster recovery
$2,500-14,000
$9,000-28,000
Keratoprosthesis — artificial cornea
$10,000-50,000
$30,000-75,000
The Costs Nobody Warns You About
Post-operative medication — topical steroids and sometimes immunosuppressants — often continues for 12 months or longer, and that's a real, ongoing cost most quotes don't mention. Follow-up visits are the actual cost nobody prices upfront. If you have disease in both eyes, budget for that separately. Healing sometimes takes longer than planned, which can extend your stay. And honestly: published one-year graft survival runs about 86%, meaning roughly one in seven grafts doesn't survive the first year — if that happens, repeat surgery is a real possibility worth planning for financially, not just hoping around.
What Makes MediGoCare Different
We publish outcomes data, including the parts that aren't flattering — real graft survival figures and a documented follow-up problem, not just the good news. We're building a follow-up plan designed to survive your flight home, which is the single most common failure point in published African corneal transplant outcomes and something no competitor addresses properly. Pricing is segmented by procedure type rather than a single confusing number that conflates a $600 quote with a $50,000 one, as several competitor sites currently do without explaining why. And like the rest of this programme, every statistic here is linked to where it came from, rather than stated as if it were simply common knowledge.
Donor Tissue and Clinical Capability
Where Your Cornea Comes From
A donor cornea can't be manufactured — it comes from a person who has chosen to donate, processed through a certified eye bank under regulated screening and quality standards, and matched to a recipient within a narrow window after donation. That's genuinely why supply is scarce almost everywhere, and especially where eye banking infrastructure is thin. If you're receiving human donor tissue, you have every right to ask where it came from and how it's traced — that's not a difficult question to answer honestly, and it shouldn't be treated as one.
Choosing the Right Procedure: PK vs DSEK vs DMEK vs Keratoprosthesis
PK replaces the entire thickness of the cornea and is the most established option. DSEK and DMEK replace only the innermost layer — generally faster recovery, lower rejection risk, with DMEK being the newer and more technically demanding of the two. Keratoprosthesis, an artificial cornea, exists specifically for when donor tissue isn't available or previous grafts have failed repeatedly — it costs more, but it doesn't depend on donor supply at all. Which one is right depends entirely on your specific diagnosis, and that's a conversation for your written opinion, not a page like this one.
Keratoconus and Corneal Cross-Linking
Keratoconus is the single most common reason for corneal transplant in the African patients studied in published research — two out of every three cases. It's worth saying plainly, even though it's the cheaper option: corneal cross-linking, done early enough, can halt keratoconus progression and sometimes avoid the need for a transplant altogether. We'd rather tell you that than sell you a bigger procedure.
After Your Transplant: Why Follow-Up Is the Whole Game
Here's an uncomfortable, honestly reported fact from the same published Kenyan research: a third of patients who received a corneal graft never made it back for their one-year follow-up, despite every one of them verbally committing to. Graft rejection is treatable if it's caught early. It's sight-threatening if it isn't. Follow-up isn't optional — it's the difference between the outcomes above holding for you personally or not.
A closer look at that same patient group found something reassuring and something practical. The reassuring part: most of the patients who didn't come back weren't unhappy with their surgery — when researchers reached them by phone, they generally reported being satisfied. They simply didn't return, for reasons that had nothing to do with the graft itself. The practical part: patients over 60, and those with certain pre-existing conditions, were meaningfully more likely to fall out of contact — which tells us exactly who needs the most proactive follow-up support, rather than leaving it to chance.
Watch for redness, sensitivity to light, a drop in vision, or pain — any of these after you're home should mean an urgent call, not a wait-and-see. We arrange a handover to a named ophthalmologist in your home city before you leave India, not after, alongside telemedicine and photo-based check-ins. We also help you plan for medication continuity in Nairobi, Lagos, Accra or Addis, since topical steroids often continue well past your trip. Interestingly, the same research that found the follow-up problem also found that bundled follow-up packages and simple messaging reminders meaningfully help — which is exactly what we've built this plan around.
Support and Access
We're building a downloadable Corneal Transplant Aftercare Guide — rejection warning signs with visuals, your medication schedule, a follow-up calendar, emergency contacts, and your home ophthalmologist's details. Given the documented link between clear understanding and graft survival, this isn't a lead magnet dressed up as care. It's meant to be genuinely used.
Conditions We Treat
Keratoconus (the leading cause in the African research we cite) · corneal scarring from infection or injury · corneal degeneration and dystrophies · failed previous graft · corneal opacity · bullous keratopathy · cataract with corneal involvement · retinal detachment · diabetic retinopathy · glaucoma · paediatric corneal disease.
Countries We Serve
Patients from Ethiopia, Cameroon, Kenya, Tanzania and Zambia are named directly in the research behind this page, alongside Nigeria, Uganda and Ghana.
Before You Decide: What Every Family Should Know
Common Mistakes
Waiting for keratoconus to "settle" instead of asking about cross-linking while it's still an option. Comparing a PK quote against a DMEK quote as if they're the same operation — they aren't. Budgeting for surgery but not for 12 months of medication afterward. Not arranging home follow-up before you travel. Ignoring early rejection signs. Assuming a graft is permanent and maintenance-free.
Questions to Ask Any Facilitator
Which procedure specifically, and why that one for me? Is the donor tissue fee included in the quote? Where does the tissue come from, and how is it traced? What's this surgeon's actual graft survival rate? Who checks my eye once I'm home? And what happens if the graft fails?
Myth vs Reality
"A corneal transplant is a whole-eye transplant" — false, whole-eye transplant isn't a procedure that exists.
"If there's no donor, nothing can be done" — false, keratoprosthesis exists precisely for this situation.
"A graft lasts forever" — false, grafts can fail, and follow-up genuinely affects whether yours does.
"Keratoconus always needs a transplant" — false, cross-linking can halt it if caught early enough.
Who Stands Behind This Guide
Every statistic here is linked to its source: published graft-survival research, eye-banking literature, and WHO's own vision-impairment data, rather than asserted the way most pages in this space do it.
It depends heavily on procedure type. PK typically runs $3,000-15,000, DSEK $3,500-18,000, DMEK $2,500-14,000, and keratoprosthesis $10,000-50,000.
Most African countries have no functioning eye bank at all. Where they do exist, such as in Ethiopia and Kenya, demand commonly outstrips local supply, and private care often relies on imported tissue, mainly from the US, which is expensive and limited.
Yes. A keratoprosthesis, or artificial cornea, is a real option when donor tissue is genuinely unavailable or repeated grafts have failed. It costs more but doesn't depend on donor supply.
PK replaces the full thickness of the cornea. DSEK and DMEK replace only the innermost layer, generally with faster recovery and lower rejection risk, with DMEK being the more advanced of the two.
Published research from a Kenyan hospital found one-year graft survival of 85.8% across all causes, rising to 89.9% for keratoconus specifically. That also means roughly one in seven grafts doesn't survive the first year — worth knowing honestly.
Rejection is possible but often treatable if caught early. Watch for redness, light sensitivity, a drop in vision, and pain. Any of these after you're home should mean an urgent call to your eye team.
Many last for years to decades, though survival isn't guaranteed indefinitely, and regular follow-up genuinely affects the outcome.
Often, yes, if caught early. Corneal cross-linking can halt progression and may avoid the need for surgery altogether. It's the more conservative option and worth discussing before assuming a transplant is inevitable.
Most patients in our research plan for two to three weeks, though this varies by procedure and how healing progresses.
A confirmed handover to a named ophthalmologist in your home city, arranged before you leave, plus telemedicine and photo-based check-ins.
Often, yes, for the best corrected vision, even after a successful graft. This varies by individual case.
It depends on your specific diagnosis and the surgeon's assessment — this is a question for your written opinion rather than a general rule.
From certified eye banks operating under regulated donation and screening standards. Tissue sourcing and traceability are legitimate questions any patient has a right to ask.
Yes. Ophthalmic disorders are among the conditions given priority consideration for Indian medical visa approval, alongside neurosurgery, cardiac, renal and transplant cases.
Ready to Start?
Send your eye reports for a written opinion — including whether a transplant is actually needed at all.
24/7 Service- Round the clock services & complete surveillance & patient care makes us
stands out from the rest.
OUR MEDICAL ASSISTANCE OTHER SERVICES
Air Ambulance
Emergency medical evacuation
Responsive medical treatment while travelling
NICU services
Better medical escort
Professional medical team to steady the patient’s critical situation
Fully-equipped urgent situation cares medical equipment
Online Doctor Consultation
Experienced doctors available for 24x7
Online consultations in just n 15 minutes
Reasonably priced rates and personalised solutions
Instant online consultations anytime, anywhere
Prepaid fees payment
Get your prescriptions instantly
Medicine
Available 24x7
100% Genuine Medicine
Fastest Home Delivery
Extra Benefits of Online Medicine Orders
All medicines are available
For international patients easy to procure Medicine
Pre & Post Arrival Services
Hassle-free medical Visa arrangement
Flight booking
Airline medical clearance
Medication, discharge summary and fit to travel certificate
Transported for direct hospital admission right from the airport
Patient Transport and flight to home country confirmed
Accommodation
Hotel arrangement nearby hospital
Arrange budget-friendly hotels
All types of food available
100% hygienic food
Hotel to hospital transportation service
24/7 Customer Assistance
Key advantages Of Medical Tourism in India
Better treatment as patients from 80 countries + receive medical treatment in India
Competitive pricing as compared to Western countries
All hospitals are recognized amongst International standards
No major waiting time for medical treatment
Currently India is rated top 5 favourite tourism destination worldwide
our real TESTIMONIALS
“She came to India for her Neurology treatment with her husband. She was successfully treated without surgery by Dr. Sandeep Vaishya Neurosurgery HOD & Executive Director. She is highly satisfied with the clinical outcomes also with her entire treatment journey and smoothly handling by team MediGocare India.”
Mrs. Ranjita Sanjel
“She came to India for her Neurology treatment with her husband. She was successfully treated by Dr. Aditya Murgai (Senior Consultant – Neurology & Movement Disorders). She is highly satisfied with the clinical outcomes also with her entire treatment journey and smoothly handling by team MediGocare India.”
Mrs. Uma Gharti
“Medigocare is an outstanding medical care company that I highly recommend to anyone seeking medical treatment in India. My wife and I, Mr. Arjun Kumar Dhungana and Mrs. Kamala Shreshta Dhungana, came all the way from Kathmandu, Nepal for neurological and orthopedic treatment through Medigocare, and we were extremely impressed with the level of service, guidance, and support provided by the team. Dr. Praveen Gupta, Principle Director of Neurology, and Dr. Subhash Jangid, Head of Director Orthopaedic & Joint Reconstruction at Fortis Memorial Research Institute in Gurgaon, Delhi, India provided exceptional care, and we are now going back to Nepal after successful treatment. Thank you so much to the entire team at Medigocare for making our medical journey to India a comfortable and stress-free experience. We highly recommend Medigocare to anyone looking for global medical care support.”
Mr Arjun Kumar Dhungana and his wife Mrs Kamala Shreshta Dhungana
“I highly recommend Medigocare for anyone seeking exceptional medical care in India. My experience as a patient there was outstanding, thanks to the exceptional treatment provided by Dr. Praveen Gupta, Principle Director of Neurology, and Dr. Arvind Khurana, Principle Director and Unit Head of Gastroenterology and Hepato-biliary at Fortis Memorial Research Institute in Gurgaon, Delhi. Their expertise, compassion, and personalized care made a huge difference in my treatment and recovery. I came all the way from Kathmandu, Nepal for my neuro and gastro treatment, and thanks to the care I received at Fortis Memorial Research Institute, I am now going back home after successful treatment. Thank you so much to the entire team at Medigocare for their dedication, support, and commitment to patient care. I will highly recommend Medigocare for anyone who is looking for global medical care support.”
Mr Shyam Kumar Chaudhary
Featured
As Featured In:
24/7 Customer Assistance
24/7 Assistance with the best medical care at your service
Best & Affordable Treatment
Quality treatment with professional & unmatched personal care
Full Language Translation Support
Our experts make your Communication easier and more transparent